Novel potential mechanisms for diabetic macular edema: leveraging new investigational approaches.
about
Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation.Intravitreal injection of commercially available ketorolac tromethamine in eyes with diabetic macular edema refractory to laser photocoagulation.A retrospective, pooled data analysis of the safety of pegaptanib sodium in the treatment of age-related macular degeneration in subjects with or without diabetes mellitusPreconditioning with endoplasmic reticulum stress mitigates retinal endothelial inflammation via activation of X-box binding protein 1.PKCζ mediates breakdown of outer blood-retinal barriers in diabetic retinopathyMicroglia/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: role of PKCζ in the Goto Kakizaki rat model.Fenofibric acid reduces fibronectin and collagen type IV overexpression in human retinal pigment epithelial cells grown in conditions mimicking the diabetic milieu: functional implications in retinal permeability.Endoplasmic reticulum stress and inflammation: mechanisms and implications in diabetic retinopathy.Prospective study of inflammatory biomarkers and risk of diabetic retinopathy in the diabetes control and complications trial.Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability.Diabetic Retinopathy and Diabetic Macular Edema.Beneficial effects of fenofibrate in retinal pigment epithelium by the modulation of stress and survival signaling under diabetic conditions.Fenofibric acid prevents retinal pigment epithelium disruption induced by interleukin-1β by suppressing AMP-activated protein kinase (AMPK) activation.Concentration of acute phase factors in vitreous fluid in diabetic macular edema.Association of monocyte chemoattractant protein-1 (MCP-1)2518A/G polymorphism with proliferative diabetic retinopathy in northern Chinese type 2 diabetes.
P2860
Q33518322-34827263-B21E-4106-8EDD-CEF46D4F280DQ33968778-21AC5840-642D-4F95-86C8-B99F399FB59EQ34370043-46BC76A1-0818-4897-8BC6-ABFC027A7230Q34575640-CCC3C6B7-8C36-4094-8519-D420E854F219Q35060608-9DFA5A57-055B-4AF7-9731-FFA94E327CF3Q35168171-755B0471-FA45-4B61-AE9E-166CE6552540Q35221085-B5D029FB-125C-40CA-8861-35A39F056151Q35928460-91E897D4-5B0A-402F-9031-41E74A03534CQ36763152-4831210D-876D-4D9F-8523-691B9D1AAF3DQ37344103-73CF365F-0633-46A7-AD46-72385C19CE4EQ38616344-15A57EE3-4D75-4F6F-8EB9-EBB7C85E27A4Q39493020-C1A45D65-8D4D-4B23-9246-2D2F591795C9Q39582504-B57C55B4-80A2-478A-BCEB-A11F4068C76CQ48014506-0083C6AD-1895-455D-8DDE-7C72B07CEF73Q54209798-FE297341-5CFF-4195-8DA6-A41AB860245D
P2860
Novel potential mechanisms for diabetic macular edema: leveraging new investigational approaches.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel potential mechanisms for ...... ew investigational approaches.
@en
Novel potential mechanisms for ...... ew investigational approaches.
@nl
type
label
Novel potential mechanisms for ...... ew investigational approaches.
@en
Novel potential mechanisms for ...... ew investigational approaches.
@nl
prefLabel
Novel potential mechanisms for ...... ew investigational approaches.
@en
Novel potential mechanisms for ...... ew investigational approaches.
@nl
P2860
P1476
Novel potential mechanisms for ...... ew investigational approaches.
@en
P2093
David A Antonetti
Thomas W Gardner
P2860
P2888
P304
P356
10.1007/S11892-008-0047-5
P577
2008-08-01T00:00:00Z